Mechanisms of cellular senescence

Current Opinion in Genetics and Development

Volumn 7, Issue 2, 1997, Pages 281-287

  Smeal, Tod ^a   Guarente, Leonard ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HELICASE;

ARTICLE; CAENORHABDITIS ELEGANS; CELL AGING; DNA METABOLISM; DNA REPAIR; GENETIC REGULATION; HUMAN; LIFESPAN; NONHUMAN; PREMATURE AGING; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STRESS; TELOMERE; TRANSCRIPTION REGULATION; WERNER SYNDROME;

EID: 0030927662     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80139-6     Document Type: Article

References (71)

1. Mortimer RK, Johnston J: Life span of individual yeast cells. Nature 1959, 183:1751-1752.
2. Pohly H: A formal mortality analysis for population of unicellular organisms. Mech Aging Dev 1987, 38:237-243.
3. Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37:614-636.
4. Kennedy BK, Austriaco NR Jr, Guarente L: Daughter cells of S. cerevisiae from old mothers display a reduced lifespan. J Cell Biol 1994, 137:1985-1993.
5. Müller I: Parental age and the lifespan of zygotes of Saccharomyces cerevisiae. J Microbiol Serol 1985, 51:1-10.
6. Egilmez NK, Jazwinski S: Evidence for the involvement of a cytoplasmic factor in the aging of the yeast Saccharomyces cerevisiae. J Bacteriol 1939, 171:37-42.
7. Kennedy B, Austriaco N, Zhang J, Guarente L: Mutation in the silencing gene SIR4 can delay aging in Saccharomyces cerevisiae. Cell 1995, 80:485-496. The authors take advantage of the correlation between stress resistance and lifespan to isolate long-lived mutants in S. cerevisiae. Interestingly, one of these mutations is in the silencing gene, SIR4. This mutation, sir4-42, results in a truncation of Sir4p carboxy-terminal domain (that is, the domain normally involved in recruitment of the SIR complex by Rap1p). Whereas sir4-42 is semidomiant for extension of lifespan, it is recessive for loss of silencing at telomeres and HM, Suggesting that this mutation may extend lifespan by altering the balance of silencing factors between HM, telomeres, and some other unknown 'age' related loci.
8. Guarente L: Do changes in chromosomes cause aging? Cell 1996, 86:1-12.
9. Ivy JM, Klar AJS, Hicks J: Cloning and characterization of four SIR genes of Saccharomyces cerevisiae. Mol Cell Biol 1986, 6:688-702.
10. Rine J, Herskowitz I: Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. Genetics 1987, 116:9-22.
11. Pillus L, Rine J: Epigenetic inheritance of transcriptional states in S. cerevisiae. Cell 1989, 59:637-647.
12. Aparicio OM, Billington BL, Gottschling DE: Modifiers of position effect are shared between telomere and silent mating-type loci in Saccharomyces cerevisiae. Cell 1991, 66:1279-1287.
13. Chien C, Buck S, Sternglanz R, Shore D: Targeting of SIR1 Protein establishes transcriptional silencing at HM loci and telomeres in yeast. Cell 1993, 75:531-541.
14. Moretti P, Freeman K, Coodly L, Shore D: Evidence that a complex of SIR proteins interacts with the silencer and telomere binding protein RAP1. Genes Dev 1994, 8:2257-2269.
15. Cockell M, Palladino F, Laroche T, Kyrion G, Liu C, Lustig AJ, Gasser SM: The carboxy termini of Sir4 and Rap1 affect Sir3 localization: evidence for a multicomponent complex required for yeast telomeric silencing. J Cell Biol 1995, 129:909-929.
16. Buck AW, Shore D: Action of a RAP1 carboxy-terminal silencing domain reveals an underlying competition between HMR and telomeres in yeast Genes Dev 1995, 9:370-384.
17. Mercand S, Buck S, Moretti P, Gilson E, Shore D; Silencing of genes at nontelomeric sites in yeast is controlled by sequestration of silencing factors at telomeres by Rap1 protein. Genes Dev 1996, 10:1297-1309.
18. Maillet L, Boscheron C, Gotta M, Mercand S, Gilson E, Gasser S: Evidence for silencing commpartments within yeast nucleus: a role for telomere proximity and Sir protein concentration in silencer-mediated repression. Genes Dev 1996, 10:1796-1811.
19. Smeal T, Claus J, Kennedy B, Cole F, Guarente L: Loss of transcriptional silencing causes sterility in old mother cells of S. cerevisiae. Cell 1996, 84:633-642. The authors employ a novel strategy to biochemically isolate and characterize old mother yeast cells. By employing a combination of biochemical and genetic strategies, they are able to demonstrate directly the breakdown of silencing in old cells, which results in the age-specific phenotype of sterility in old yeast mother cells.
20. Hayflick L: The limited in vitro lifespan of human diploid cell strains. Exp Cell Res 1965, 37:614-636.
21. Rohme D: Evidence for a relationship between longevity of mammalian species and normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA 1981, 78:5009-5013.
22. Pereira-Smith OM, Smith JR: Genetic analysis of indefinite division in human cells: identification of four complementation greoups. Proc Natl Acad Sci USA 1988, 85:6042-6046.
23. Noda A, Ning Y, Venable S, Pereira-Smith O, Smith JR: Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211:90-98.
24. CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996, 16:859-867.
25. Waft/Cip1/Sdi1 related protein, correlates with measurement of the finite proliferative potential of rodent fibroblasts. Proc Natl Acad Sci USA 1997 94:151-156.
26. Dimri G, Lee X, Basile G, Acosta M, Scott G, Roskelly C, Medrano E, Linskens M, Rubeli J, Pereira-Smith O et al.: A biomarker that identifies senescent human cells in culture and aging skin in vivo. Proc Natl Acad Sci USA 1995, 92: 9363-9357.
27. Wareham K, Lyon M, Glenister P, Williams E: Age related reactivation of an X linked gene. Nature 1987, 327:725-727.
28. Holliday R: The inheritance of epigenetic defects. Science 1987, 238:163-170.
29. Ogryzko V, Hirai T, Russanova V, Barbie D, Howard, B: Human fibroblast commitment to a senescent like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 1995, 16:5210-5218.
30. Yu C, Oshima J, Fu Y, Wijsmar E, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S et al.: Positional cloning of the Werner's syndrome gene. Science 1996, 272:258-262. Culmination of years of study of WRN by the cloning of the gene responsible and identification of some of the mutant alleles. The cloning was a technically demanding accomplishment given the rarity of the disorder. An important discovery that may lead to insights into the role defects in DNA metabolism may play in human aging.
31. Epstein C, Martin G, Schultz A, Motulsky A: Werner's syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 1966, 45:177-221.
32. Faragher R, Kill I, Hunter J, Pope F, Tannock C, Shall S: The gene responsible for Werner's syndrome may be a cell division "counting" gene. Proc Natl Acad Sci USA 1993, 90:12030-12034.
33. Salk D, Au K, Hoehn H, Martin G: Cytogenics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet Cell Genet 1981, 30:92-107.
34. Fukuchi K, Martin G, Monnat R: Mutator phenotype of Werner's syndrome is characterized by extensive deletions. Proc Natl Acad Sci USA 1989, 86:5393-5897.
35. Cheng R, Murano S, Kurz B, Shmookler-Reis R: Homologous recombination is elevated in some Werner like syndromes but not during normal in vitro or in vivo senescence of mammalian cells. Mutant Res 1990, 237:259-269.
36. Goto M, Miller R, Ishikawa Y, Sugano H: Excess of rare cancers in Werner's syndrome. Cancer Epidemiol Biomarkers Prev 1996, 5:239-246.
37. Webb D, Evans M, Bohr V: DNA repair fine structure in Werner's syndrome cell lines. Exp Cell Res 1996, 224:272-278.
38. Schulz V, Zakian V, Ogburn C, McKay J, Jarzebowicz A, Edland S, Martin G: Accelerated loss of telomeric repeats may not explain decline of Werner syndrome cells. Hum Genet 1996, 97:750-754.
39. Lu J, Mullen J, Brill S, Kleff S, Romeo A, Sternglanz R: Human homologues of yeast helicase. Nature 1996, 383:678-679.
40. Gangloff S, McDonald J, Bendixen C, Arthur L, Rothstein R: The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol Cell Biol 1994, 14:8391-3398.
41. Watt P, Louis E, Borts R, Hickson I: Sgs1: A eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation. Cell 1995, 81:253-260.
42. Blasco M, Funk W, Villepontaeu B, Greider C: Functional characterization and developmental regulation of mouse tetomerase RNA. Science 1995, 269:1267-1270.
43. Feng J, Funk W, Wang S, Weinrich S, Avilion A, Chiu C, Adams R, Chang E, Allsopp R, Yu J et al.: The RNA component of human telomerase. Science 1995, 269:1236-1241.
44. Collins K, Kobayashi R, Greider C: Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme, Cell 1995, 81:677-696.
45. Harley CB, Futcher AB, Greider C: Telomere shorten during aging of human fibroblasts. Nature 1990, 345:458-460.
46. Allsopp RC, Vaziri H, Palerson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89:10114-10118.
47. Henderson S, Allsopp R, Spector D, Wang S, Harley C; In situ changes in telomere size during replicative aging and cell transformation. J Cell Biol 1996, 134:1-12.
48. De Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994, 91:2862-2885.
49. Broccoli D, Godley L, Donehower L, Varmus H, De Lange T: Telomerase activation in mouse mammary tumors: lack of detectable telomere shortnening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol 1996, 16:3765-3772. To determine whether telomere loss results in selection for tumor cells that express telomerase, the authors of this study examine the regulation of telomerase activity during the induction of mouse mammary tumors. On the assumption that, because of the very long telomeres of the strain they employ, there should be no selection for telomerase expression during the immortalization of cells - as the authors note, given the wide chromosomal variation of telomere length, its hard to completely exclude the possibility that telomere shortning of one or a few chromosomes leads to senescence even in Mus musculus. Yet telomerase activity is upregulated during development of mammary tumors. Additionally, they find that telomerase activity is regulated by a cell's proliferation state. The authors suggest several possibilities for upregulation of telomerase activity - other than the maintenance of a single 'clock' telomere, the increase in telamerase activity may either be important for healing damaged chromosomes, possibly play a structural role, or may merely be caused by the higher proliferatives state of the tumor cells.
50. Prowse KR, Greider C: Development and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995, 92:4618-4822. An interesting study of telomerase dynamics in the mouse strain Mus spretus, which has telomeres of similiar length to humans. Telomeres shorten with increasing population doublings in Mus spretus though, surprisingly, most normal Mus spretus tissues have telomerase activity (unlike humans) and the average telomere length varies in a tissue-specific manner. The authors suggest that the more stringent control of telomerase activity in human somatic cells may be because of the need of the longer-lived human cells to suppress unregulated proliferation such as cancer.
51. Broccoli D, Young J, De Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92:9092-9086.
52. Bryan T, Englezou A, Gupta J, Bacchetti S, Reddel R: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14:4240-4248.
53. Blasco M, Rizen M, Greider C, Hanahan D: Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996, 12:200-204. The authors of this report show that upregulation of telomerase RNA is an early event in multistage tumorigenesis. Surprisingly, the induction of telomerase activity is not coordinately regulated with telomerase RNA and the induction of telomerase activity is a relatively late event. (For further discussion of telomerase regulation in mouse, see [49**,50**].)
54. Strahl C, Blackburn H: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996, 16:53-65.
55. D'Mello NP, Jazwinski S: Telomere length constancy during aging of Saccharomyces cerevisiae. J Bacteriol 1990, 173:6709-6713.
56. Wang S, Zakian V: Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature 1990, 345:456-458.
57. Lundbland V, Blackburn E: An alternative pathway for yeast telomere maintenance rescues est-senescence. Cell 1993, 73:347-360.
58. Li B, Lustig A: A novel mechanism for telomere size control in Saccharomyces cerevisiae. Genes Dev 1996, 10:1310-1326.
59. McEachern M, Blackburn E: Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev 1996. 10:1822-1834.
60. Gottlieb S, Ruvkun G: daf-2, daf-16 and daf-23: genetically interacting genes controlling dauer formation in Caenorhabditis elegans. Genetics 1994, 137:107-120.
61. Golden J, Riddle D: The C. elegans dauer larva: developmental effects of pheramone, food, and temperature. Dev Biol 102:368-379.
62. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R; A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
63. Larson P, Albert P, Riddle D: Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 1995, 139:1567-1583. By dissecting the complex epistatic relationships of the various daf genes that influence lifespan, the authors are able to establish the genetic pathway by which daf-23, daf-18, dat12, daf-2, and daf-16 control lifespan.
64. Morris JZ, Tissenbaum H, Ruvkun G: A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 1996, 382:536-539. The original aging gene in C. elegans, age-1 , is here shown to be the same gene as daf-23, is cloned and found to be related to mammalian P1(3)K p110 catalytic subunits. Furthermore, maternally rescued daf-23(m333) progeny (which harbor a nonconditional Daf-c allele; offspring of maternally rescued homozygous daf-23 parents unconditionally arrest as either pre-dauer L2d or as dauer larvae) have mean lifespans -170% greater than wild-type worms.
65. Friedman D, Johnson T: A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 1968, 118:75-36.
66. Dorman J, Albinder B, Shroyer T, Kenyon C: The age-1 and daf-2 genes function in a common pathway to control lifespan of Caenorhabditis elegans. Genetics 1995, 141:1399-1406. The authors show that both daf-2 and age-1 require daf-16 and daf-18 for their ability to extend lifespan, indicatiing strongly that age-1 acts via the dauer pathway and is probably a daf gene - indeed, subsequently, age-1 was shown to be the same gene as daf-23. (See also [64**,67].)
67. Malone E, Inoue T, Thomas J: Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics 1995, 143:1193-1205.
68. Yeh W: Genes acting late in the signalling pathway for Caenorhabditis elegans dauer larval development [Ph.D. Thesis]. Columbia, University of Missouri; 1991.
69. Murakami S, Johnson T: A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans. Genetics 1996, 143:1207-1218. An interesting study that correlates whether a variety of long-lived associated stress-resistant phenotypes such as thermotolerance, hydrogen peroxide resistance, and UV resistance correlate with lifespan extension in worms harboring various alleles of daf-16, age-1, daf-2, clock-1, spe-26, fer-15. The authors propose that lifespan extension is through a single daf-16-dependent pathway - in part caused by various genetic interactions and in part because all these genes confer UV resistance - through which age-1/daf-23, daf-2, clock-1, spe-26 extend lifespan.
70. Wong A, Boutis P, Hekimi S: Mutations in the clock-1 gene of Caenorhabdis elegans affect developmental and behavioral timing. Genetics 1895, 139:1247-1259. The authors of this paper engage in a search for maternal-effect mutations that affect internal biological clocks in C. elegans. They describe the isolation of clock-1 and characterize the pleiotropic nature of clock-1, establish its numerous effects on a variety of biological clocks and show that alleles of clock-1 can extend lifespan.
71. Lakowski B, Hekimi S: Determination of life-span in Caenorhabditis elegans by four clock genes. Science 1996, 272:1010-1013. These authors show that genes controlling physiological timing systems in C. elegans can extend its adult lifespan dramatically. The clock genes can cooperate with the daf genes (daf-2) to extend lifespan up tc six-fold. Amazingly, clock-1 effects an lifespan can be maternally rescued.